vs
Cytek Biosciences, Inc.（CTKB）与FIRST FINANCIAL CORP（THFF）财务数据对比。点击上方公司名可切换其他公司
FIRST FINANCIAL CORP的季度营收约是Cytek Biosciences, Inc.的1.1倍（$70.5M vs $62.1M），FIRST FINANCIAL CORP净利率更高（30.4% vs -70.9%，领先101.3%），FIRST FINANCIAL CORP同比增速更快（14.1% vs 8.1%），FIRST FINANCIAL CORP自由现金流更多（$86.4M vs $-1.8M），过去两年FIRST FINANCIAL CORP的营收复合增速更高（20.8% vs 17.7%）
Cytek Biosciences主营高性能流式细胞分析系统、配套试剂及分析软件的研发、生产与商业化，产品服务覆盖生命科学研究、临床诊断、生物制药开发等领域，客户遍及全球多个主要地区。
第一美国金融公司是一家美国金融服务企业，主营为房地产与抵押贷款行业提供产权保险以及结算服务，深耕相关金融领域，是该细分赛道具备专业能力的服务提供商。
CTKB vs THFF — 直观对比
营收规模更大
THFF
是对方的1.1倍
$62.1M
营收增速更快
THFF
高出6.0%
8.1%
净利率更高
THFF
高出101.3%
-70.9%
自由现金流更多
THFF
多$88.2M
$-1.8M
两年增速更快
THFF
近两年复合增速
17.7%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $70.5M |
| 净利润 | $-44.1M | $21.5M |
| 毛利率 | 52.9% | — |
| 营业利润率 | -9.0% | 37.4% |
| 净利率 | -70.9% | 30.4% |
| 营收同比 | 8.1% | 14.1% |
| 净利润同比 | -557.1% | 32.1% |
| 每股收益（稀释后） | — | $1.81 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CTKBTHFF
| Q4 25 | $62.1M | $70.5M | ||
| Q3 25 | $52.3M | $65.8M | ||
| Q2 25 | $45.6M | $63.1M | ||
| Q1 25 | $41.5M | $62.5M | ||
| Q4 24 | $57.5M | $61.8M | ||
| Q3 24 | $51.5M | $58.4M | ||
| Q2 24 | $46.6M | $49.2M | ||
| Q1 24 | $44.9M | $48.4M |
净利润CTKBTHFF
| Q4 25 | $-44.1M | $21.5M | ||
| Q3 25 | $-5.5M | $20.8M | ||
| Q2 25 | $-5.6M | $18.6M | ||
| Q1 25 | $-11.4M | $18.4M | ||
| Q4 24 | $9.6M | $16.2M | ||
| Q3 24 | $941.0K | $8.7M | ||
| Q2 24 | $-10.4M | $11.4M | ||
| Q1 24 | $-6.2M | $10.9M |
毛利率CTKBTHFF
| Q4 25 | 52.9% | — | ||
| Q3 25 | 52.7% | — | ||
| Q2 25 | 52.3% | — | ||
| Q1 25 | 48.6% | — | ||
| Q4 24 | 58.5% | — | ||
| Q3 24 | 56.3% | — | ||
| Q2 24 | 54.6% | — | ||
| Q1 24 | 51.3% | — |
营业利润率CTKBTHFF
| Q4 25 | -9.0% | 37.4% | ||
| Q3 25 | -17.6% | 39.2% | ||
| Q2 25 | -23.3% | 36.2% | ||
| Q1 25 | -36.1% | 38.1% | ||
| Q4 24 | 5.2% | 32.4% | ||
| Q3 24 | -8.2% | 17.9% | ||
| Q2 24 | -18.3% | 27.6% | ||
| Q1 24 | -23.9% | 27.2% |
净利率CTKBTHFF
| Q4 25 | -70.9% | 30.4% | ||
| Q3 25 | -10.5% | 31.6% | ||
| Q2 25 | -12.2% | 29.5% | ||
| Q1 25 | -27.5% | 29.5% | ||
| Q4 24 | 16.8% | 26.3% | ||
| Q3 24 | 1.8% | 15.0% | ||
| Q2 24 | -22.4% | 23.1% | ||
| Q1 24 | -13.8% | 22.6% |
每股收益（稀释后）CTKBTHFF
| Q4 25 | — | $1.81 | ||
| Q3 25 | — | $1.75 | ||
| Q2 25 | — | $1.57 | ||
| Q1 25 | — | $1.55 | ||
| Q4 24 | — | $1.37 | ||
| Q3 24 | — | $0.74 | ||
| Q2 24 | — | $0.96 | ||
| Q1 24 | — | $0.93 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $90.9M | — |
| 总债务越低越好 | — | $188.2M |
| 股东权益账面价值 | $341.7M | $650.9M |
| 总资产 | $461.5M | $5.8B |
| 负债/权益比越低杠杆越低 | — | 0.29× |
8季度趋势，按日历期对齐
现金及短期投资CTKBTHFF
| Q4 25 | $90.9M | — | ||
| Q3 25 | $93.3M | — | ||
| Q2 25 | $75.5M | — | ||
| Q1 25 | $95.3M | — | ||
| Q4 24 | $98.7M | — | ||
| Q3 24 | $162.3M | — | ||
| Q2 24 | $177.9M | — | ||
| Q1 24 | $168.8M | — |
总债务CTKBTHFF
| Q4 25 | — | $188.2M | ||
| Q3 25 | — | $170.5M | ||
| Q2 25 | — | $122.7M | ||
| Q1 25 | — | $124.9M | ||
| Q4 24 | — | $28.1M | ||
| Q3 24 | — | $30.5M | ||
| Q2 24 | — | $108.6M | ||
| Q1 24 | — | $58.6M |
股东权益CTKBTHFF
| Q4 25 | $341.7M | $650.9M | ||
| Q3 25 | $378.6M | $622.2M | ||
| Q2 25 | $377.6M | $587.7M | ||
| Q1 25 | $379.6M | $571.9M | ||
| Q4 24 | $395.7M | $549.0M | ||
| Q3 24 | $385.5M | $566.0M | ||
| Q2 24 | $389.1M | $530.7M | ||
| Q1 24 | $392.6M | $520.8M |
总资产CTKBTHFF
| Q4 25 | $461.5M | $5.8B | ||
| Q3 25 | $494.9M | $5.7B | ||
| Q2 25 | $493.3M | $5.6B | ||
| Q1 25 | $482.6M | $5.5B | ||
| Q4 24 | $499.5M | $5.6B | ||
| Q3 24 | $491.2M | $5.5B | ||
| Q2 24 | $483.7M | $4.9B | ||
| Q1 24 | $492.1M | $4.9B |
负债/权益比CTKBTHFF
| Q4 25 | — | 0.29× | ||
| Q3 25 | — | 0.27× | ||
| Q2 25 | — | 0.21× | ||
| Q1 25 | — | 0.22× | ||
| Q4 24 | — | 0.05× | ||
| Q3 24 | — | 0.05× | ||
| Q2 24 | — | 0.20× | ||
| Q1 24 | — | 0.11× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-771.0K | $90.4M |
| 自由现金流经营现金流 - 资本支出 | $-1.8M | $86.4M |
| 自由现金流率自由现金流/营收 | -2.9% | 122.5% |
| 资本支出强度资本支出/营收 | 1.6% | 5.6% |
| 现金转化率经营现金流/净利润 | — | 4.21× |
| 过去12个月自由现金流最近4个季度 | $-8.8M | $144.3M |
8季度趋势，按日历期对齐
经营现金流CTKBTHFF
| Q4 25 | $-771.0K | $90.4M | ||
| Q3 25 | $-3.9M | $26.9M | ||
| Q2 25 | $108.0K | $12.7M | ||
| Q1 25 | $-125.0K | $21.1M | ||
| Q4 24 | $2.0M | $60.4M | ||
| Q3 24 | $13.2M | $23.3M | ||
| Q2 24 | $6.2M | $8.8M | ||
| Q1 24 | $4.0M | $12.4M |
自由现金流CTKBTHFF
| Q4 25 | $-1.8M | $86.4M | ||
| Q3 25 | $-4.6M | $25.8M | ||
| Q2 25 | $-1.5M | $11.6M | ||
| Q1 25 | $-974.0K | $20.5M | ||
| Q4 24 | $1.1M | $54.3M | ||
| Q3 24 | $12.2M | $19.5M | ||
| Q2 24 | $5.2M | $8.4M | ||
| Q1 24 | $3.4M | $11.5M |
自由现金流率CTKBTHFF
| Q4 25 | -2.9% | 122.5% | ||
| Q3 25 | -8.7% | 39.2% | ||
| Q2 25 | -3.2% | 18.4% | ||
| Q1 25 | -2.3% | 32.8% | ||
| Q4 24 | 1.9% | 87.8% | ||
| Q3 24 | 23.7% | 33.5% | ||
| Q2 24 | 11.0% | 17.2% | ||
| Q1 24 | 7.6% | 23.7% |
资本支出强度CTKBTHFF
| Q4 25 | 1.6% | 5.6% | ||
| Q3 25 | 1.3% | 1.7% | ||
| Q2 25 | 3.5% | 1.8% | ||
| Q1 25 | 2.0% | 0.9% | ||
| Q4 24 | 1.6% | 9.9% | ||
| Q3 24 | 2.0% | 6.5% | ||
| Q2 24 | 2.3% | 0.7% | ||
| Q1 24 | 1.3% | 2.0% |
现金转化率CTKBTHFF
| Q4 25 | — | 4.21× | ||
| Q3 25 | — | 1.29× | ||
| Q2 25 | — | 0.68× | ||
| Q1 25 | — | 1.14× | ||
| Q4 24 | 0.21× | 3.72× | ||
| Q3 24 | 14.05× | 2.67× | ||
| Q2 24 | — | 0.77× | ||
| Q1 24 | — | 1.14× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CTKB
| Products | $46.6M | 75% |
| Services | $15.5M | 25% |
THFF
暂无分部数据
